Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Oracle Corporation (ORCL) Reports Mixed Results and Smart Money Saw That Coming

Enterprise software giant Oracle Corporation (NYSE:ORCL) came out with mixed fiscal 2016 first quarter results after the market closed on Wednesday. Currency headwinds and the decline in sales of its traditional software packages hurt the company during the quarter, but it displayed continuing progress in its cloud-based software business. Oracle Corporation (NYSE:ORCL) reported revenue of $8.45 billion, which declined by 1.7% on the year, but in constant currency terms it was up by 7%. On the other hand, analysts were expecting the company to report revenue of $8.53 billion. Sales of Oracle’s on-Premise software business fell by 2% year-over-year to $5.8 billion, whereas total cloud revenues rose by 29% to $611 million.

Oracle ORCL

Ken Wolter/

In addition, Oracle Corporation (NYSE:ORCL)’s net income declined to $1.75 billion or $0.40 per share from $2.18 billion or $0.48 per share reported for the same period last year. Excluding for other items and stock based compensation, the company’s EPS for the quarter stood at $0.53, which although was significantly down from the $0.62 posted a year earlier, was slightly above the consensus estimate of $0.52. The company didn’t provide any guidance for the coming quarter or the full year, however, the its CTO and Executive Chairman, Larry Ellison, said:

“We are still on target to book between $1.5 and $2.0 billion of new SaaS and PaaS business this fiscal year. That means Oracle would sell between 50% more and double the amount of new cloud business than plans to sell in their current fiscal year.”

After remaining sideways for nearly the first half of the year, Oracle Corporation (NYSE:ORCL)’s stock has slid since June and currently is trading down by 15.57% year-to-date. However, one metric that can suggest to investors what to expect from a stock’s performance is the hedge fund sentiment. That’s why we analyze 13F filings of over 700 hedge funds from our database on a quarterly basis.

We pay attention to the hedge fund sentiment even though most investors ignore their moves because, as a group, hedge funds’ average net returns trailed the market since 2008 by a large margin. Unfortunately, most investors don’t realize that hedge funds are hedged so they are likely to lag the market in a bullish environment. We ignore their short positions and our research has shown that hedge funds’ long picks generate strong risk-adjusted returns. For instance the 15 most popular small-cap stocks outperformed the S&P 500 Total Return Index by an average of 95 basis points per month in our backtests spanning the 1999-2012 period. We have been tracking the performance of these stocks in real-time since the end of August 2012 and we weren’t proven wrong. These 15 stocks managed to return more than 118% over the last 36 months and outperformed the S&P 500 Index by some 60 percentage points (see the details here).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.